9 Helpful HPV Resources for Patients and Health Workers

Share

Helpful HPV links for public health officials and individuals

Navigating the breadth of information on Human Papillomavirus (HPV) and its associated health risks can be a challenge. To help you explore further, we’ve compiled this list of a few HPV resources and tools:

FOR PUBLIC HEALTH PROFESSIONALS

If you are a public health decision-maker, you’ll find the HPV Vaccine Cost Calculator by PATH a useful tool. It helps estimate the costs of introducing HPV vaccination programs in low-resource areas by considering vaccine costs, delivery methods, and target populations.

Keeping track of the global vaccination efforts against HPV is now simplified with the World Health Organization (WHO) Immunization Data Portal. Offering global and country-specific data about HPV vaccine introduction and coverage, it presents timely insights on progress, thus acting as a pivotal tool for disease eradication and elimination efforts.

The HPV and Related Diseases Report by the HPV Information Center is a concise yet comprehensive resource on HPV and its associated diseases. It navigates complex issues like screening practices and causative factors of cervical cancer, making it an indispensable guide for anyone keen to understand and combat HPV-related diseases.

The World Health Organization (WHO) launched the first global initiative to eliminate cervical cancer, primarily caused by HPV. This plan focuses on HPV vaccination, screenings, and efficient treatment. It highlights the importance of prevention and early detection in managing this disease, especially in low- and middle-income countries.

Read more about the Global HPV Consortium
Join the Global HPV Community on Boost

FOR INDIVIDUALS

For informed decision-making regarding the HPV vaccine, the HPV Vaccine Decision Tool from Alberta Health Services in Canada is a useful starting point. It provides detailed information, including foundational knowledge about HPV, the vaccine’s safety, and recommended vaccination schedules. This tool offers an evidence-based platform to support health decisions by addressing common misconceptions and concerns.

CervicalRisk, a platform based on research from Boston University, with input from the National Cancer Institute, Centers for Disease Control and Prevention, and the American Cancer Society, helps comprehend and manage abnormal Pap tests, HPV test results, and cervix biopsy results. It delineates the potential steps a healthcare provider might take after encountering abnormal results.

For young women seeking understanding about HPV, the Centers for Disease Control and Prevention (CDC) fact sheet, “HPV Vaccine Information For Young Women,” provides comprehensive information. It outlines the role of the vaccine in preventing cancer and offers guideance on the ideal age and dosage for the vaccine.

Dive deeper into the history, necessity, safety, and effectiveness of HPV vaccines with the Vaccine Education Center from the Children’s Hospital of Philadelphia. This resource clears misconceptions and accentuates the vaccine’s role in preventing HPV-related cancers.

In December 2022, the WHO updated their HPV vaccine guidelines and announced that a single dose now offers protection similar to the previous two-dose regimen. This simplification aims to enhance global access to the vaccine and fight cervical cancer more effectively, especially in underprivileged areas.